Back

Quality of life before and after pulmonary vein isolation for atrial fibrillation: results of a multicenter cohort study in the Netherlands

25 August 2023 (16:15 - 17:00)
Organised by: Logo
Congress Presentation Part of: Prognosis and outcome in patients with atrial fibrillation Epidemiology, Prognosis, Outcome ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speakers

Photo
Mr Tom Oirbans

St Antonius Hospital, Nieuwegein (Netherlands (The))

Photo
Doctor Jippe Balt

St Antonius Hospital, Nieuwegein (Netherlands (The))

7 More presentations in this session

Presentation thumbnail
Cigarette smoking and structural brain deficits in patients with atrial fibrillation
Mr R. Peter (Basel, CH)
Abstract Slides Video
Presentation thumbnail
Clinical characteristics of apixaban prescription in AF patients with single dose-reduction criterion: ASPIRE (efficacy and safety of apixaban in real-world practice in Korean frail patients with AF)
Miss J. Choi (Seoul, KR)
Abstract Slides Video
Presentation thumbnail
The current and future total health care costs of atrial fibrillation
Doctor R. Sandhu (Calgary, CA)
Abstract Slides Video
Presentation thumbnail
Association of atrial fibrillation burden with rhythm control and stroke prevention interventions among patients with cardiac implantable electronic devices
Doctor G. Peigh (Chicago, US)
Abstract Slides Video
Presentation thumbnail
Risk differences between atrial fibrillation patients with different clinical phenotypes: insights from the French population
Doctor A. Fawzy (Liverpool, GB)
Abstract Slides Video

Access the full session

Session thumbnail
Prognosis and outcome in patients with atrial fibrillation

The Event

Event poster

ESC Congress 2023

25 August 2023 16:15 CET
You may be interested in
thumbnail
Congress Presentation
Quality of life after pulmonary veins isolation: outcomes from a digital follow-up program
thumbnail
Congress Presentation
Patient-reported quality of life after atrial fibrillation ablation: a real-world study
thumbnail
Congress Presentation
Clinician-reported EHRA and NYHA scores only moderately reflect patient-reported quality of life in atrial fibrillation and heart failure

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources